DDInter1606 DDInter1082
Adrenergic beta-agonist used to control premature labor.
Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type II diabetes mellitus (T2DM). It is sold by Sanofi-Aventis under the brand name Adlyxin in the US and Lyxumia in the EU. Adlyxin recieved FDA approval July 28, 2016.
Ritodrine {u} (Compound) resembles {v} (Compound) Arformoterol
Ritodrine {u} (Compound) resembles {v} (Compound) Dobutamine
Ritodrine {u} (Compound) binds {v} (Gene) GALR3
Ritodrine {u} (Compound) upregulates {v} (Gene) TGFBR2
Ritodrine {u} (Compound) downregulates {v} (Gene) POLR2I
Ritodrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Flunisolide
Ritodrine {u} may cause a minor interaction that can limit clinical effects when taken with {v} Ciclesonide
Ritodrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Isoprenaline
Ritodrine {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Phenylpropanolamine
Ritodrine {u} may lead to a major life threatening interaction when taken with {v} Ivosidenib
Ritodrine (Compound) resembles Arformoterol (Compound)
Ritodrine (Compound) resembles Dobutamine (Compound)
Ritodrine (Compound) binds GALR3 (Gene)
Ritodrine (Compound) upregulates TGFBR2 (Gene)
Ritodrine (Compound) downregulates POLR2I (Gene)
Ritodrine may cause a minor interaction that can limit clinical effects when taken with Flunisolide
Ritodrine may cause a minor interaction that can limit clinical effects when taken with Ciclesonide
Ritodrine may cause a moderate interaction that could exacerbate diseases when taken with Isoprenaline
Ritodrine may cause a moderate interaction that could exacerbate diseases when taken with Phenylpropanolamine
Ritodrine may lead to a major life threatening interaction when taken with Ivosidenib